Genolution Inc. (KOSDAQ: 225220)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,915.00
-65.00 (-2.18%)
Oct 11, 2024, 9:00 AM KST

Genolution Company Description

Genolution Inc. manufactures and sells IVD products in South Korea and internationally.

Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination.

The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits.

It also provides siRNA/shRNA synthesis service to inhibit gene expression and other gene related services; and long dsRNA synthesis service to inhibit gene expression by injecting RNA into various living organisms.

The company was founded in 2006 and is based in Seoul, South Korea.

Genolution Inc.
Country South Korea
Founded 2006
Industry Surgical and Medical Instruments and Apparatus
CEO Ki-Ok Kim

Contact Details

Address:
Building A
Seoul, 05836
South Korea
Phone 82 2 449 8670
Website genolution1.com

Stock Details

Ticker Symbol 225220
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 3841

Key Executives

Name Position
Ki-Ok Kim Chief Executive Officer